Search

Author/Creator Romagnoli, D.

1. Clinical relevance of accurate HCV genotype and subtype assignment by NS3/NS5A/NS5B direct sequencing in the era of new direct acting antiviral agents. (10th February 2016)

Authors:
Aragri, M.; Di Maio, V.C.; Di Paolo, D.; Cento, V.; De Leonardis, F.; Gianserra, L.; Tontodonati, M.; Micheli, V.; Landonio, S.; Manunta, A.; Bertoli, A.; Ciotti, M.; Antonucci, F.P.; Campoli, R.; La Rosa, K. Yu; Deodati, F.; Lenci, I.; Francioso, S.; Nicolini, L.A.; Marenco, S.
Journal:
Digestive and liver disease
Issue:
Volume 48(2016)Supplement 1
Page Start:
e1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Cryptogenic cirrhosis is associated with cardiometabolic and oncologic comorbidities and poor liver-related prognosis. (7th October 2015)

Authors:
Nascimbeni, F.; Restivo, L.; Masetti, C.; Amelia, A.; Ballestri, S.; Nevola, R.; Baldelli, E.; Rinaldi, L.; Romagnoli, D.; Guerrera, B.; Zampino, R.; Giordano, M.; Lonardo, A.; Adinolfi, L.E.
Journal:
Digestive and liver disease
Issue:
Volume 47(2015)Supplement 3
Page Start:
e221
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels. (17th December 2015)

Authors:
Di Maio, V. C.; Cento, V.; Di Paolo, D.; Aragri, M.; De Leonardis, F.; Tontodonati, M.; Micheli, V.; Bellocchi, M. C.; Antonucci, F. P.; Bertoli, A.; Lenci, I.; Milana, M.; Gianserra, L.; Melis, M.; Di Biagio, A.; Sarrecchia, C.; Sarmati, L.; Landonio, S.; Francioso, S.; Lambiase, L.
Journal:
Journal of antimicrobial chemotherapy
Issue:
Volume 71:Number 3(2016:Mar.)
Page Start:
739
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. HCV resistance test guided retreatments after protease inhibitors failures can induce maximal efficacy rate in real-life. Issue 1 (16th February 2017)

Authors:
Cento, V.; Barbaliscia, S.; Lenci, I.; Ruggiero, T.; Masetti, C.; Magni, C.F.; Micheli, V.; Paolucci, S.; Troshina, Y.; Biliotti, E.; Milana, M.; Melis, M.; Teti, E.; Lambiase, L.; Menzaghi, B.; Nicolini, L.A.; Marenco, S.; Di Maio, V.C.; Aragri, M.; Pecchioli, A.
Journal:
Digestive and liver disease
Issue:
Volume 49:Issue 1(2017)Supplement
Page Start:
e53
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Long-term prospective study of development of hepatocellular carcinoma in compensated cirrhosis. (February 2020)

Authors:
Pivetti, A.; Todesca, P.; Bernabucci, V.; Lei, B.; Buono, M. Del; Turco, L.; Schepis, F.; Bianchini, M.; De Maria, N.; Romagnoli, D.; Carulli, L.; Casari, F.; Caporali, C.; Felaco, D.; Villa, E.
Journal:
Digestive and liver disease
Issue:
Volume 52(2020)Supplement 1
Page Start:
e61
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Multiclass HCV resistance to interferon-free direct acting antivirals regimens in real life failures advocates for tailored second-line therapies. Issue 1 (16th February 2017)

Authors:
Di Maio, V.C.; Cento, V.; Lenci, I.; Aragri, M.; Barbaliscia, S.; Francioso, S.; Paolucci, S.; Melis, M.; Verucchi, G.; Masetti, C.; Coppola, N.; Magni, C.F.; Micheli, V.; Pollicino, T.; Ruggiero, T.; Landonio, S.; Mancon, A.; Starace, M.; De Leonardis, F.; Santopaolo, F.
Journal:
Digestive and liver disease
Issue:
Volume 49:Issue 1(2017)Supplement
Page Start:
e49
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Natural HCV resistance is common in Italy and differently associated to genotypes. Issue 1 (16th February 2017)

Authors:
Sorbo, M.C.; Cento, V.; Bertoli, A.; Lenci, I.; Polilli, E.; Masetti, C.; Gianserra, L.; Teti, E.; Biliotti, E.; Magni, C.F.; Aragri, M.; Micheli, V.; Melis, M.; Nicolini, L.A.; Marenco, S.; Calvaruso, V.; Paolucci, S.; Baldanti, F.; Morisco, F.; Siciliano, M.
Journal:
Digestive and liver disease
Issue:
Volume 49:Issue 1(2017)Supplement
Page Start:
e52
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Presence of resistance associated variants in patients with virological failure to new direct acting antivirals and requirement of unconventional regimens for re-treatment. (10th February 2016)

Authors:
Di Maio, V.C.; Cento, V.; Di Paolo, D.; Lenci, I.; Aragri, M.; Verucchi, G.; Melis, M.; Bertoli, A.; Antonucci, F.P.; Francioso, S.; Pellicelli, A.; Calvaruso, V.; Pasquazzi, C.; Romagnoli, D.; Rosa, K. Yu La; Campoli, R.; Biolato, M.; Vecchiet, J.; Sorbo, M.C.; Morisco, F.
Journal:
Digestive and liver disease
Issue:
Volume 48(2016)Supplement 1
Page Start:
e3
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. The independent predictors of NASH and its individual histological features. Insulin resistance, serum uric acid, metabolic syndrome, ALT and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment. (7th October 2015)

Authors:
Ballestri, S.; Nascimbeni, F.; Romagnoli, D.; Lonardo, A.
Journal:
Digestive and liver disease
Issue:
Volume 47(2015)Supplement 3
Page Start:
e229
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗